SOTYKTU 6 mg/1

SOTYKTU 6 mg/1 is a medication containing deucravacitinib, used for managing specific inflammatory conditions. This oral tablet is designed to help alleviate symptoms and improve quality of life.

SOTYKTU 6 mg/1 is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Deucravacitinib, the active ingredient, works by targeting specific pathways involved in inflammation. Patients often wonder, 'What is SOTYKTU used for?' It is generally prescribed for conditions where inflammation plays a key role.

Common effects of SOTYKTU 6 mg/1 may include nausea, diarrhea, and upper respiratory tract infections. Some users might experience fatigue or headaches. These effects can vary from person to person and are not experienced by everyone who takes the medication.

SOTYKTU 6 mg/1 should be handled with care. It is important to follow the advice of a healthcare provider regarding its use. Patients with a history of serious infections or certain types of cancer should discuss this with their doctor before starting the medication. Always store the tablets in a cool, dry place away from direct sunlight.

SOTYKTU 6 mg/1 may interact with other medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods might also interact with the medication, so it's best to consult with a healthcare professional for personalized advice.